Federal contract award

75N95020F00001

AN ORAL THERAPY FOR THE PREVENTION AND TREATMENT OF MALARIA. POP: 09/16/2020 TO 03/15/2021.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIDA
NAICS541712
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleHHSN271201700014I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$432.4K
Current contract value$432.4K
Potential contract value / ceiling$432.4K
Start dateSep 16, 2020
Current end dateJul 23, 2021
Potential end dateJul 23, 2021
Latest award activityJul 30, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 30, 2026P00005$-6.7KTO ADMINISTRATE DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
Apr 12, 2021P00004$0AN ORAL THERAPY FOR THE PREVENTION AND TREATMENT OF MALARIA. POP: 09/16/2020 TO 07/23/2021. MOD P00004 TO RESCIND AUTHORIZATION FOR A FIXED-PRICE SUBCONTRACT WITH VDX AND INCREASE THE AUTHORIZED AMOUNT FOR A FIXED-PRICE SUBCONTRACT WITH EPL.
Mar 8, 2021P00003$124.4KAN ORAL THERAPY FOR THE PREVENTION AND TREATMENT OF MALARIA. POP: 09/16/2020 TO 07/23/2021. MOD P00003 TO EXTEND THE PERIOD OF PERFORMANCE TO 07/23/2021; OBLIGATE SUPPLEMENTAL FUNDS FOR REVISED COSTS AND SOW CHANGES; AND MODIFY SECTIONS B, F, AND J T
Feb 5, 2021P00002$0AN ORAL THERAPY FOR THE PREVENTION AND TREATMENT OF MALARIA. POP: 09/16/2020 TO 03/15/2021. MOD TO CHANGE THE PRINCIPAL INVESTIGATOR, MODIFY SECTION G TO UPDATE CONTRACT CLAUSES, AND MODIFY SECTION J TO DELETE THE INTERIM ELECTRONIC INVOICING INSTRUC
Sep 29, 2020P00001$0AN ORAL THERAPY FOR THE PREVENTION AND TREATMENT OF MALARIA. POP: 09/16/2020 TO 03/15/2021. MODIFICATION FOR KEY PERSONNEL CHANGE.
Sep 15, 20200$314.7KAN ORAL THERAPY FOR THE PREVENTION AND TREATMENT OF MALARIA. POP: 09/16/2020 TO 03/15/2021.

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.